
DEPT
FACULTY
COVID-19 Contribution
01 Apr 2023
Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is uncertain. Objective: To examine the real-world effectiveness of mo...Read more
31 Dec 2022
Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited...Read more
08 Jun 2022
Background: Observable symptoms of Bell's palsy following vaccinations arouse concern over the safety profiles of novel coronavirus disease 2019 (COVI...Read more
17 May 2022
Importance: COVID-19 has required universities to rapidly develop vaccination policies for students and staff, yet little is known about the preferenc...Read more
08 Aug 2023
Antibiotics may increase the risk of COVID-19 among non-vaccinated subjects via probable gut dysbiosis. We aimed to investigate whether antibiotics al...Read more
03 May 2023
BACKGROUND: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where da...Read more
07 Mar 2022
Researchers from the Department of Pharmacology and Pharmacy of the LKS Faculty of Medicine at The University of Hong Kong found intramuscular olanzap...Read more
01 Dec 2022
Background: The World Health Organization has defined a list of adverse events of special interest (AESI) for safety surveillance of vaccines. AESI ha...Read more
01 Jul 2021
Identifying effective drug treatments for COVID-19 is essential to reduce morbidity and mortality. Although a number of existing drugs have been propo...Read more
20 May 2023
BACKGROUND: Inactivated, whole-virion vaccines have been used extensively in the SARS-CoV-2 pandemic. Its efficacy and effectiveness across regions ha...Read more
08 Aug 2023
Background: Antibiotics may increase the risk of COVID-19 among non-vaccinated subjects via probable gut dysbiosis. We aimed to investigate whether an...Read more
31 Dec 2023
Severe COVID-19 appears to be disproportionately more common in children and adolescents since the emergence of Omicron. More evidence regarding vacci...Read more
02 Dec 2022
Introduction: In Hong Kong, CoronaVac and BNT162b2 have been approved for emergency use owing to the coronavirus disease 2019 (COVID-19) pandemic. Rea...Read more
01 Apr 2022
Background: Stimulation of immunity by vaccination may elicit adverse events. There is currently inconclusive evidence on the relationship between her...Read more
22 Feb 2023
01 Jun 2023
Background People with substance use disorder have a high risk of SARS-CoV-2 infection and subsequent poor outcomes. Few studies have evaluated COVID-...Read more
27 Dec 2022
BACKGROUND: In view of limited evidence that specifically addresses vaccine effectiveness (VE) in the older population, this study aims to evaluate th...Read more
20 Feb 2023
Background: Multimorbidity is a prevalent risk factor for COVID-19–related complications and death. We sought to evaluate the association of homologou...Read more
01 Nov 2022
27 Jul 2022
Aims: Concern about the cardiovascular safety of coronavirus disease 2019 (COVID-19) vaccines among individuals with cardiovascular disease (CVD) may ...Read more